We demonstrated that Ab@Tf-Cou6-PLGA NPs could specifically degrade BCR/ABL protein via the Trim-Away pathway and suppress the pathogenesis of CML cells in vivo and in vitro. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.